Theraclone Provides Update on BARDA Funding Proposal for TCN-032 for Serious and Pandemic Flu

28-11-2013 Business Wire HealthComments (0)

PharmaceuticalTheraclone Sciences

Theraclone Sciences provides update on BARDA funding proposal for TCN-032 for serious and pandemic flu.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top